STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Biogen
Related studies linked through entity extraction aliases.
Avonex PEN Satisfaction and Patients Experience Clinical Trial
- Status
- COMPLETED
- Phase
- N/A
A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
- Status
- TERMINATED
- Phase
- PHASE3
Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple Sclerosis
- Status
- WITHDRAWN
- Phase
- PHASE3
Psychometric Validation of Cognitive Endpoints
- Status
- COMPLETED
- Phase
- N/A
Long-Term Safety and Efficacy Study of Peginterferon Beta-1a
- Status
- COMPLETED
- Phase
- PHASE3
Longitudinal Pharmacokinetic, Pharmacodynamic, Immunological, and Biochemical
- Status
- COMPLETED
- Phase
- N/A
A Safety Study in Healthy Volunteers of the Single-Use Autoinjector Containing Placebo of BG9418 Interferon Beta-1a With a 25-Gauge × 1-Inch Needle
- Status
- TERMINATED
- Phase
- PHASE1
Alternate Dosing Regimens of BG00012 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Avonex-evaluation of Quality of Life and Convenience in Belgian Participants - The AVAIL Study
- Status
- COMPLETED
- Phase
- N/A
Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With Natalizumab
- Status
- UNKNOWN
- Phase
- N/A
Safety Study of BIIB033 in Subjects With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PF-04958242 in Healthy Adult Volunteers
- Status
- TERMINATED
- Phase
- PHASE1
Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials.
- Status
- COMPLETED
- Phase
- PHASE3
A Pharmacokinetics (PK) and Safety Study of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
- Status
- COMPLETED
- Phase
- N/A
Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)
- Status
- TERMINATED
- Phase
- PHASE4
Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
- Status
- TERMINATED
- Phase
- N/A
JC-virus (JCV) Epidemiology in Multiple Sclerosis (MS)
- Status
- COMPLETED
- Phase
- N/A